OSR Holdings, Inc.
OSRHNASDAQHealthcareBiotechnology
Previous close
$0.277
−$0.0179 · -6.07%
Pre-market
$0.27
−$0.007 · -2.53%
Aug 24, 6:35 AM ET
OSRH company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
65
Undervalued
Momentum
18
Strong Down
Sentiment
58
Mixed
Risk resilience
34
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteOSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses. The company was incorporated on February 25, 2020, and maintains its principal office in Bellevue, Washington.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Kuk Hyoun Hwang
- Listed since
- Mar 21, 2023
- Employees
- 22
Market position
Day range
Current $0.277
52-week range
Current $0.277
- Open
- $0.31
- Previous close
- $0.2949
- Volume
- 4.82M
- 0.45× average
- Average volume
- 10.72M
- Average daily volume
- Market cap
- 9.18M USD
- Beta
- 0.58
- Market reference 1
- 50-day average
- $0.3871
- -28.43% below average
- 200-day average
- $0.5166
- -46.38% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 5.23M USD
- P/E (TTM)
- -0.08×
- P/B (TTM)
- 0.01×
- P/S (TTM)
- 5.07×
- EV / EBITDA
- -0.27×
- Earnings yield
- -712.37%
- Free cash flow yield
- -178.16%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- -98.82%
- Operating margin
- -933.75%
- Net margin
- -836.91%
- Return on equity
- -23.20%
- Return on assets
- -10.52%
- Return on invested capital
- -10.84%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 0.16×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.91M USD | 3.53M USD | — | — | — |
| Cost of goods sold | 2.31M USD | 2.72M USD | — | — | — |
| Gross profit | 592.91K USD | 811.24K USD | — | — | — |
| Research and development | 318.45K USD | 161.16K USD | — | — | — |
| Selling, general, and administrative | 9.19M USD | 2.54M USD | 1.83M USD | 35.39K USD | 3.31K USD |
| Operating expenses | 18.93M USD | 12.5M USD | 1.83M USD | 35.39K USD | 3.31K USD |
| Interest income | 63.88K USD | 1.45M USD | 2.78M USD | — | — |
| Interest expense | 506.2K USD | 43.01K USD | — | — | — |
| Depreciation and amortization | 9.31M USD | 9.69M USD | 2.78M USD | 228.49K USD | 236.56K USD |
| Operating income | −18.34M USD | −11.69M USD | −1.83M USD | −35.39K USD | −3.31K USD |
| Net income | −18.01M USD | −10.33M USD | 403.78K USD | −35.39K USD | −3.31K USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 75%
- 3 beats, 1 miss, 0 met estimates
- Average EPS surprise
- -435.38%
- 4 comparable reports
- Latest EPS result
- -0.02
- Estimate -0.28 · Beat by 92.86%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
OSRH news
OSRH peers
ETFs holding OSRH
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research OSRHresearch.disclaimer